Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petr Jarolim

Showing results (81-90 of 187) with videos related to

Pageof 19
Sort By:
Journal of the American Heart Association|April 6, 2018
IL-23R Deficiency Does Not Impact Atherosclerotic Plaque Development in MiceDaniel Engelbertsen, Marie A C Depuydt, Robin A F Verwilligen, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 12, 2008
Preoperative B-type natriuretic peptide is as independent predictor of ventricular dysfunction and mortality after primary coronary artery bypass graftingAmanda A Fox, Stanton K Shernan, Charles D Collard, et al.
Journal of the American College of Cardiology|November 27, 2007
Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trialJames A de Lemos, David A Morrow, Michael A Blazing, et al.
Clinical Chemistry and Laboratory Medicine|February 3, 2019
Prognostic role of GDF-15 across the spectrum of clinical risk in patients with NSTE-ACSThomas A Zelniker, Petr Jarolim, Michael G Silverman, et al.
JAMA Cardiology|October 6, 2016
Cardiovascular Biomarker Score and Clinical Outcomes in Patients With Atrial Fibrillation: A Subanalysis of the ENGAGE AF-TIMI 48 Randomized Clinical TrialChristian T Ruff, Robert P Giugliano, Eugene Braunwald, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 20, 2006
Abrogation of functional selectin-ligand expression reduces migration of pathogenic CD8+ T cells into heartYi Hong Cai, Angeles Alvarez, Pilar Alcaide, et al.
Clinical Cardiology|January 24, 2014
Diagnostic performance of copeptin in patients with acute nontraumatic chest pain: BWH-TIMI ED chest pain studyDevraj Sukul, Marc P Bonaca, Christian T Ruff, et al.
Journal of the American Heart Association|April 22, 2021
Cardiovascular Biomarkers and Heart Failure Risk in Stable Patients With Atherothrombotic Disease: A Nested Biomarker Study From TRA 2°P-TIMI 50David D Berg, Benjamin L Freedman, Marc P Bonaca, et al.
Journal of the American College of Cardiology|June 6, 2006
Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 studyBenjamin M Scirica, David A Morrow, Christopher P Cannon, et al.
Journal of the American College of Cardiology|March 20, 2010
B-type natriuretic peptide and the effect of ranolazine in patients with non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary-Thrombolysis In Myocardial Infarction 36) trialDavid A Morrow, Benjamin M Scirica, Marc S Sabatine, et al.
Pageof 19

Showing results (81-90 of 187) with videos related to

Sort By:
Pageof 19
Journal of the American Heart Association|April 6, 2018
IL-23R Deficiency Does Not Impact Atherosclerotic Plaque Development in MiceDaniel Engelbertsen, Marie A C Depuydt, Robin A F Verwilligen, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 12, 2008
Preoperative B-type natriuretic peptide is as independent predictor of ventricular dysfunction and mortality after primary coronary artery bypass graftingAmanda A Fox, Stanton K Shernan, Charles D Collard, et al.
Journal of the American College of Cardiology|November 27, 2007
Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trialJames A de Lemos, David A Morrow, Michael A Blazing, et al.
Clinical Chemistry and Laboratory Medicine|February 3, 2019
Prognostic role of GDF-15 across the spectrum of clinical risk in patients with NSTE-ACSThomas A Zelniker, Petr Jarolim, Michael G Silverman, et al.
JAMA Cardiology|October 6, 2016
Cardiovascular Biomarker Score and Clinical Outcomes in Patients With Atrial Fibrillation: A Subanalysis of the ENGAGE AF-TIMI 48 Randomized Clinical TrialChristian T Ruff, Robert P Giugliano, Eugene Braunwald, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 20, 2006
Abrogation of functional selectin-ligand expression reduces migration of pathogenic CD8+ T cells into heartYi Hong Cai, Angeles Alvarez, Pilar Alcaide, et al.
Clinical Cardiology|January 24, 2014
Diagnostic performance of copeptin in patients with acute nontraumatic chest pain: BWH-TIMI ED chest pain studyDevraj Sukul, Marc P Bonaca, Christian T Ruff, et al.
Journal of the American Heart Association|April 22, 2021
Cardiovascular Biomarkers and Heart Failure Risk in Stable Patients With Atherothrombotic Disease: A Nested Biomarker Study From TRA 2°P-TIMI 50David D Berg, Benjamin L Freedman, Marc P Bonaca, et al.
Journal of the American College of Cardiology|June 6, 2006
Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 studyBenjamin M Scirica, David A Morrow, Christopher P Cannon, et al.
Journal of the American College of Cardiology|March 20, 2010
B-type natriuretic peptide and the effect of ranolazine in patients with non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary-Thrombolysis In Myocardial Infarction 36) trialDavid A Morrow, Benjamin M Scirica, Marc S Sabatine, et al.
Pageof 19